These final results, along with a past report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a unique way to modulate the opioid process, which could open new therapeutic avenues for opioid-related Conditions. Improve much healthier immune perform: https://stepheng147qnj8.blogs100.com/profile